Twins Study of Gene Therapy for HIV Infection

NCT00001535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
HIV Infection
Kaposi's Sarcoma

Interventions

DRUG: Syngeneic Lymphocytes (CD4+) Cultured with OKT3 (Ortho) and Interleukin-2 (Chiro

Sponsor

National Human Genome Research Institute (NHGRI)